Abstract
Oxidative mechanisms involving lipid peroxidation in the subendothelium of the arterial vessel wall play a key role in atherogenesis. Despite severe hyperlipidaemia, patients with glycogen storage disease type la (GSD1a) do not develop premature atherosclerosis. Therefore, we analysed parameters of antioxidative defence and oxidative stress in plasma and serum of patients with GSD1a (n=17) and compared them with those of patients with type 1 diabetes mellitus (n=17), familial hypercholesterolaemia (n=18) and healthy controls (n=20). We measured the total radical trapping ability parameter (TRAP), single plasma antioxidants (sulfhydryl-groups, uric acid, vitamin C, alpha-tocopherol, coenzyme-Q10), markers of lipid peroxidation, lipoprotein (a) and homocysteine. Patients with GSD1a showed an elevated TRAP (P<0.01) compared to the three other groups. This can mainly be attributed to elevated uric acid levels (P<0.05 versus control). Lipoprotein (a) was significantly lower in the GSD1a group compared to the three other groups (P<0.05).Conclusion: Patients with glycogen storage disease type 1a show an increased antioxidative defence in plasma which may protect them against lipid peroxidation and thus against premature atherosclerosis. Our finding of low lipoprotein (a) levels in this small group of patients warrants further investigation in a greater number of patients before assessing its role in atherogenesis in glycogen storage disease type 1a.
Similar content being viewed by others
Abbreviations
- DM1 :
-
diabetes mellitus type 1
- FH :
-
familial hypercholesterolaemia
- GSD1a :
-
glycogen storage disease type 1a
- LDL :
-
low density lipprotein
- Lp(a) :
-
lipoprotein (a)
- MDA :
-
malondiadehyde
- TRAP :
-
total radical trapping ability parameter
References
Kugiyama K, Sugiyama S (1992) Lysophosphatidylcholine mediates surface receptor-mediated intracellular signals in endothelial cells by a pathway involving protein kinase C activation. Circ Res 71: 1422–1428.
Hansson (1997) Cell-mediated immunity in atherosclerosis. Curr Opin Lipidol 8: 301–311
Belcher JD, Balla J, Balla G et al (1993) Vitamin E, LDL and endothelium. Brief oral vitamin supplementation prevents LDL-mediated vascular injury in vitro. Arterioscler Thromb Vasc Biol 13: 1779–1789
Devaraj S, Li D, Jialal I (1996) The effects of alpha-tocopherol supplementation on monocyte function: decreased lipid peroxidation, interleukin 1β- secretion, and monocyte adhesion to endothelium. J. Clin Invest 98: 756–763.
Diaz MN, Frei B, Vita JA, Keaney JF Jr (1997) Mechanisms of disease: antioxidants and atherosclerotic heart disease. N Engl J Med 337: 408–416
Fuster V, Badimon L, Badimon JJ, Chesebro JH (1992) The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 326: 310–318
Navab M, Berliner, JA, Watson AD, et al (1996) The yin and yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture. Arterioscler Thromb Vasc Biol 16:831–842.
Schmitz G, Hohage H, Ullrich K (1993) Glucose 6 phosphate: a key compound in glycogenosis I and favism leading to hyper-or hypolipidemia. Eur J. Pediatr 152[Suppl 1]: S77-S84.
Brownlee M, Cerami A, Vlassara H (1994) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318: 1315–1321
Wayner DDM, Burton GW, Ingold KU, Barclay LRC, Lockey SJ (1987) The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochim. Biophys. Acta 924: 408–419
Dürken M, Herrnring C, Finckh B, Nagel S, Nielsen P, Fischer R, Berger HM, Moison RMW, Pichlmeier U, Kohlschütter B, Zander AR, Kohlschütter A (2000) Impaired plasma antioxidative defense and increased nontransferrin-bound iron during high-dose chemotherapy and radiochemotherapy preceding bone marrow transplantation. Free Radic Biol Med 28: 887–894
Ellmann GL (1959) Tissue sulfhydryl groups. Arch Biochem. Biophys 82: 70–72
Omaye ST, Turnbull JD, Sauberlich HE (1979) Selected methods for the determination of ascorbic acid in animal cells, tissues, and fluids. Methods Enzymol 62: 3–11.
Finckh B, Kontush A, Commentz J, Hübner C, Burdelski M, Kohlschütter A (1999) HPLC analysis of ubiquinol-10, ubiquinone-10, carotenoids, and tocopherols in neonatal plasma—coulometric electrochemical detection. Methods Enzymol 299: 341–348
Fukunaga K, Suzuki T, Takama K (1993) Highly sensitive high-performance liquid chromatography for the measurement of malondialdehyde in biological samples. J. Chromatog 621: 77–81.
Zöllner N, Kirsch Z (1962) Über die quantitative Bestimmung von Lipoiden (Mikromethode) mittels der vielen natürlichen Lipoiden (allen bekannten Plasmalipoiden) gemeinsamen Sulfophosphovanillin-Reaktion. Z. ges exp Med 135: 545–547
Lee PJ, Celermajer DS, Robinson, J, McCarthy SN, Betteridge DJ, Leonard JV (1994) Hyperlipidemia does not impair vascular endothelial function in glycogen storage disease type 1a. Atherosclerosis 110: 95–110.
Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340: 1111
Clarkson P, Celermajer JD, Powe AJ, Donald AE, Henry RM, Deanfield JE (1997) Endothelium dependent dilatation is impaired in young healthy subjects with a family history of premature coronary disease. Circulation 96: 3378–3383.
Rosengren A, Wilhelmsen L, Eriksson E, Risberg B, Wedel H (1990) Lipoprotein(a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. BMJ 301: 1248–1251.
Utermann G (1989) The mysteries of lipoprotein(a). Science 246: 904–910.
Sandholzer C.H.D., Saha N, Sigurdsson D et al. Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups. Hum Genet 86: 607–614; 1991.
Boerwinkle ELC, Lin J, Lackner C, Chiesa G, Hobbs HH (1992) Apolipoprotein(a) gene accounts for greater than 90% of the variations in lipoprotein(a) concentrations. J. Clin Invest 90: 52–60.
Mancini FP, Mooser V, Guerra R, Hobbs HH (1995) Sequence microheterogeneity in apolipoprotein(a) gene repeats and the relationship to plasma Lp(a) levels. Hum Mol Genet 4: 1535–1542.
Galle JBengenJ, Schollmeyer P, Wanner C (1995) Impairment of endothelium dependent vasodilation in rabbit renal arteries by oxidized lipoprotein(a). Role of oxygen-derived radicals. Circulation 92: 1582–1589
Sorensen KE, C.D., Georgakopoulos D, Hatcher G, Betteridge DJ, Deanfield LE. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolaemia and is related to the lipoprotein(a) level. J. Clin Invest 93: 50; 1994.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published online: 19 September 2002
Rights and permissions
About this article
Cite this article
Wittenstein, B., Klein, M., Finckh, B. et al. Radical trapping in glycogen storage disease 1a. Eur J Pediatr 161, S70–S74 (2002). https://doi.org/10.1007/BF02679999
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02679999